SAMANTHA SENDER: Open Payments
NPI 1245984459 · LUTHERVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 35 payments from 17 companies in 2025. Trend: 2023 $582 · 2024 $898 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $460 |
| CVRx, Inc. | 3 | $202 |
| United Therapeutics Corporation | 5 | $137 |
| Travere Therapeutics, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 4 | $119 |
| Melinta Therapeutics, LLC | 2 | $115 |
| ABIOMED | 2 | $54 |
| ABBVIE INC. | 2 | $51 |
| Novo Nordisk Inc | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System, Filspari, Rezzayo, UPTRAVI, Remodulin, Orenitram, CARDIOMEMS.
Industry payments across MD — which companies pay providers there.
